Neurotensin

CAS No. 39379-15-2

Neurotensin( —— )

Catalog No. M30009 CAS No. 39379-15-2

Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 76 In Stock
5MG 154 In Stock
10MG 217 In Stock
25MG 435 In Stock
50MG 613 In Stock
100MG 860 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Neurotensin
  • Note
    Research use only, not for human use.
  • Brief Description
    Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.
  • Description
    Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Neurotensin receptors (NTR)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39379-15-2
  • Formula Weight
    1672.92
  • Molecular Formula
    C78H121N21O20
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 33.33 mg/mL (19.92 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Fluoranthene

    Fluoranthene is a chemical compound.

  • Lenthionine

    Lenthionine is a marine derived natural products found in Chondria acrorhizophora.

  • MID-1

    MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.?It disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.